Lixil Stock Current Valuation
| JSGCFDelisted Stock | USD 11.54 0.00 0.00% |
Valuation analysis of LIXIL helps investors to measure LIXIL's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that LIXIL's price fluctuation is very steady at this time. Calculation of the real value of LIXIL is based on 3 months time horizon. Increasing LIXIL's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the LIXIL otc stock is determined by what a typical buyer is willing to pay for full or partial control of LIXIL. Since LIXIL is currently traded on the exchange, buyers and sellers on that exchange determine the market value of LIXIL OTC Stock. However, LIXIL's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.54 | Real 10.79 | Hype 11.54 |
The real value of LIXIL OTC Stock, also known as its intrinsic value, is the underlying worth of LIXIL OTC Stock, which is reflected in its stock price. It is based on LIXIL's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of LIXIL's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of LIXIL helps investors to forecast how LIXIL otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of LIXIL more accurately as focusing exclusively on LIXIL's fundamentals will not take into account other important factors: LIXIL OTC Stock Current Valuation Analysis
LIXIL's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current LIXIL Current Valuation | 8.01 B |
Most of LIXIL's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LIXIL is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, LIXIL has a Current Valuation of 8.01 B. This is 9.96% higher than that of the Industrials sector and significantly higher than that of the Building Products & Equipment industry. The current valuation for all United States stocks is 51.83% higher than that of the company.
LIXIL Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LIXIL's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of LIXIL could also be used in its relative valuation, which is a method of valuing LIXIL by comparing valuation metrics of similar companies.LIXIL is currently under evaluation in current valuation category among its peers.
LIXIL Fundamentals
| Return On Equity | 0.0485 | |||
| Return On Asset | 0.0123 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 8.01 B | |||
| Shares Outstanding | 287.06 M | |||
| Shares Owned By Insiders | 2.65 % | |||
| Shares Owned By Institutions | 53.17 % | |||
| Price To Earning | 15.22 X | |||
| Price To Book | 0.93 X | |||
| Price To Sales | 0 X | |||
| Revenue | 1.43 T | |||
| Gross Profit | 486.87 B | |||
| EBITDA | 154.13 B | |||
| Net Income | 48.6 B | |||
| Cash And Equivalents | 126.99 B | |||
| Cash Per Share | 440.51 X | |||
| Total Debt | 337.51 B | |||
| Debt To Equity | 0.90 % | |||
| Current Ratio | 1.17 X | |||
| Book Value Per Share | 2,217 X | |||
| Cash Flow From Operations | 118.3 B | |||
| Earnings Per Share | 0.74 X | |||
| Number Of Employees | 51.64 K | |||
| Beta | 1.03 | |||
| Market Capitalization | 4.84 B | |||
| Total Asset | 1.78 T | |||
| Retained Earnings | 239.89 B | |||
| Working Capital | 116.66 B | |||
| Current Asset | 856.53 B | |||
| Current Liabilities | 739.88 B | |||
| Annual Yield | 0.05 % | |||
| Net Asset | 1.78 T | |||
| Last Dividend Paid | 45.0 |
About LIXIL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LIXIL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LIXIL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LIXIL based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the LIXIL information on this page should be used as a complementary analysis to other LIXIL's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in LIXIL OTC Stock
If you are still planning to invest in LIXIL check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LIXIL's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |